Background: Percutaneous coronary interventions to implant bioresorbable vascular
scaffolds (BVSs) were designed to reduce the late thrombotic events that occur with metallic …

Aim: To compare the periprocedural outcomes and patient profile of BVS and DES/BMS
implantation in an all-comer population from the ORPKI Polish National Registry. Material …

Background Patients presenting with acute coronary syndrome (ACS) are at increased risk
of complications after percutaneous coronary intervention with stent placement compared to …

Objectives We sought to determine the relationship between the degree of left ventricular
ejection fraction (LVEF) impairment and the frequency and type of bleeding events after …

Aim The aim of our study was to propose a modified Mehran restenosis classification
adapted to bifurcation lesions and preliminarily assess its value in the 4-year follow-up on …

This chapter provides a short overview of the pathophysiology and the treatment options in
the case of bioresorbable scaffolds (BRSs) failure with a focus on the most frequently used …

Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural
support and drug release to prevent early recoil or restenosis, and then degrades into …

Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold
(Absorb) in stable angina and acu Page 1 144 Advances in Interventional Cardiology 2018; 14 …

New-generation drug-eluting stents are recommended as the default option in all clinical
conditions and lesion subsets in patients undergoing percutaneous coronary intervention …

Comparison of the Absorb bioresorbable vascular scaffold to the Xience durable polymer
everolimus-eluting metallic stent in rout Page 1 149 Advances in Interventional Cardiology …